Development and Modeling of a Biosensor Platform using AlGaN/GaN HEMT Devices by Tulip, Fahmida Shaheen
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
Doctoral Dissertations Graduate School
12-2014
Development and Modeling of a Biosensor
Platform using AlGaN/GaN HEMT Devices
Fahmida Shaheen Tulip
University of Tennessee - Knoxville, ftulip@vols.utk.edu
This Dissertation is brought to you for free and open access by the Graduate School at Trace: Tennessee Research and Creative Exchange. It has been
accepted for inclusion in Doctoral Dissertations by an authorized administrator of Trace: Tennessee Research and Creative Exchange. For more
information, please contact trace@utk.edu.
Recommended Citation
Tulip, Fahmida Shaheen, "Development and Modeling of a Biosensor Platform using AlGaN/GaN HEMT Devices. " PhD diss.,
University of Tennessee, 2014.
https://trace.tennessee.edu/utk_graddiss/3176
To the Graduate Council:
I am submitting herewith a dissertation written by Fahmida Shaheen Tulip entitled "Development and
Modeling of a Biosensor Platform using AlGaN/GaN HEMT Devices." I have examined the final
electronic copy of this dissertation for form and content and recommend that it be accepted in partial
fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Electrical
Engineering.
Syed K. Islam, Major Professor
We have read this dissertation and recommend its acceptance:
Jayne Wu, Gong Gu, Ramki Kalyanaraman
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)
Development and Modeling of a Biosensor Platform using 
AlGaN/GaN HEMT Devices 
 
 
 
 
 
 
A Dissertation Presented for the 
Doctor of Philosophy 
Degree 
The University of Tennessee, Knoxville 
 
 
 
 
 
 
 
Fahmida Shaheen Tulip 
December 2014 
ii 
 
 
Dedicated to 
 
My parents  
Dr. A. K. M. Shamsuddin 
Asia Khatun 
 
My better half 
 M. Shahriar Jahan 
 
 
My sisters  
Farzana Shirin 
Farhana Sharmeen 
 
 
 
  
iii 
 
Acknowledgements 
 
 
First of all, I would like to express my heartfelt gratitude to Dr. Syed Kamrul Islam, my major advisor. 
Without his support, his guidance, and his encouragement this work would have been impossible. Special 
thanks go to Dr. Jayne Wu, Dr. Gong Gu, Dr. Ramki Kalyanaraman for serving in my committee and for 
reviewing my work. 
 
I am grateful to Dr. Edward Eteshola for giving me the opportunity work in the HEMT based biosensor 
which became the topic of my dissertation. I am also thankful to Dr. Ida Lee for her discussions regarding 
the workings photosystems I. Also the members of Oak Ridge National Laboratory, specially Dale 
Hensley, Nickolay Lavrik and Timothy McKnight for their valuable discussions and suggestions for 
fabrication and development of the VACNF based glucose sensor. Dr. Asif Khan of University of South 
Carolina provided the HEMT devices used for testing purposes in this thesis and made the work possible. 
Dr. Muhammad Seraj Uddin and Dr. Shahinur Rahman of UTK also helped me by providing some 
necessary chemicals and equipment for test set-up. 
 
I am also grateful to the present and past members of the Analog, VLSI and Devices Laboratory in UTK 
for their continuous support and valuable guidance. Specially Dr. Sazia Eliza, Dr. Hasina Haque, Dr. 
Touhidur Rahman, Dr. Salwa Mostafa helped me throughout various stages of my research. Dr. Kai Zhu, 
Dr. Melika Roknsharifi, Dr. Ashraf Islam, Dr. Aminul Haque, Terence Randall, Kimberly MacArthur, 
Logan Taylor, Ifana Mahbub, Farhan Qayium, Tan Yang, Nicholas Poore, Sanjib Das, Habib Ullah 
Habib, Khandaker Abdullah Al Mamun made my time in UT a pleasant and worthwhile one.  
 
I am also thankful to the faculty and stuff of the EECS department in UTK, specially Dr. Nicole 
Macfarlane, Dr. Tolbert, Dr. Paul Crilly, Dr. Ortal Arel, Ms. Dana Bryson and Ms. Julia Evans for their 
continuous support. 
iv 
 
 
Last but not the least; I would like to thank my family members, my parents, my husband and my sisters, 
who always had faith in me.  
  
v 
 
Abstract 
 
The history of biosensors began in 1962 with the invention of enzyme electrodes by Leland C. Clark. 
Since then, biosensors have come a long way with simultaneous contributions in various fields such as 
biology, chemistry, material science, electronics, physics and VLSI. With the advancement in science and 
technology, smaller, more sensitive and dependable biosensors have become a reality. Still the need for 
cost-effective, sophisticated, reliable, robust biosensors that can be used to detect multiple types of 
biomolecules remains a technological challenge to be resolved. 
 
The proposed AlGaN/GaN High Electron Mobility Transistors (HEMTs) have excellent prospect to 
become the biosensor platform of the future, as is investigated in this work in contrast to other types of 
biosensors. These devices excel over their silicon counterparts because of their inherent properties such as 
chemically stable bulk and surface properties and the availability of high-density two-dimensional 
electron gas (2DEG) at the hetero-interface which allows a highly sensitive detection of the surface-
charge related phenomena. Using a floating gate configuration, only the drain current changes pertinent to 
biomolecule immobilization are observed. The test results are correlated with an analytical model which 
provides insight into the device physics. The high mobility and sensitivity inherent in its material system 
as well as device structure, robustness due to wide bandgap and system-level advantages make it the 
ultimate choice as a biosensor platform.  
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Chapter 1 
Introduction 
1.1 Introduction 
The demand for diagnosing and monitoring of chemical and biomolecular analytes are increasing day by 
day. Fast, reliable, ultrasensitive, portable sensor systems are of utmost importance for detecting these 
analytes. Particularly, electrochemical biosensors demonstrate relative simplicity, portability, low cost 
and low power requirement which make them excellent candidates for detecting a wide range of species, 
including proteins, nucleic acids, small molecules and viruses. Because of the recent trend of point of care 
application, this class of biosensors is rapidly becoming an important diagnostic tool. By incorporating 
integrated systems, carefully optimized functionalization of the sensor is supported by associated 
electronics, fluidics and separation technology. The potential for an extensive breakthrough of biosensor 
platform technology is a real possibility. 
 
This chapter describes the motivation and objective of the research and summarizes the outline of the 
dissertation.  
 
1.2 Motivation of Research 
Modern day sensors have come a long way from their predecessors, which used transistors realized in 
bulky semiconducting materials. Advent of micro-fabrication technology has led to the miniaturization of 
biosensors. However, biosensors market is still characterized by slower pace of commercialization, which 
is primarily attributed to high cost, availability of effective alternative technologies, and issues related to 
stability, sensitivity, and quality assurance. Biosensors in medical and environmental applications still 
remain a hugely untapped market, attracting researchers as well as entrepreneurs, with the hope of 
leveraging dormant market opportunities. 
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Potential applications of biosensors include: 
1. Food analysis 
2. Study of biomolecules and their interaction 
3. Drug development 
4. Crime detection 
5. Medical diagnosis (both clinical and laboratory use) 
6. Environmental field monitoring 
7. Quality control 
8. Industrial process control 
9. Detection systems for biological warfare agents 
10. Manufacturing of pharmaceuticals and replacement organs  
 
Biosensors
NonclinicalClinical
In vivo In vitro
Implantable 
(Long term)
Invasive 
(Short term)
Single shot Multianalyses
Single 
analysis
Reactive 
Monitoring
Environmental 
Bioagent 
detection
Artificial 
organs
Bedside 
glucose 
monitoring
Home 
glucose 
monitoring
Pathology 
lab glucose 
monitoring
Fruit 
ripening
Pollution 
monitoring
Anthrax, 
cholera, 
plague
 
Figure 1.1: Potential applications of biosensors. 
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The global market for biosensors is projected to reach US $18.9 billion by the year 2019 from US $9.9 
billion in 2012, at a compound annual growth rate of 9.6% [1]. Recent trends show that medical 
applications remain the dominant field in the global market for biosensors. Percentage revenue in 
worldwide biosensor market is shown in Figure 1.2. 
 
 
Figure 1.2: Global biosensor market in 2009 [2]. 
 
A robust, sensitive, cost effective biosensor platform can reap the benefits of leading the way in this 
emerging field. The proposed AlGaN/GaN high electron mobility transistors as investigated in this work 
have excellent prospect of becoming the biosensor platform of the future in contrast to other types of 
biosensors. Its high mobility and sensitivity inherent in its material system as well as device structure, 
robustness due to wide bandgap, and system level advantages makes it the ultimate choice for biosensor 
device. 
 
47.9%
19.2%
12.6%
11.2%
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Point of Care
Home Diagnostic
Environmental
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Process Industries
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1.3 Biosensors 
According to International Union of Pure and Applied Chemistry (IUPAC), a biosensor is a self-
contained integrated device that is capable of producing specific quantitative or semi-quantitative 
analytical information using a biological recognition element which is in direct contact spatial with a 
transducing element.  
 
A biosensor uses specific biochemical reactions to detect chemical compounds in biological samples. It 
comprises verily of two elements: a biological recognition element that interacts with the target analyte, 
and a transducing element that converts the recognition event into measurable signal.  
 
Electrical signal
Bioreceptor
Transducer
Physiochemical signal
Transduction
Recognition
Complex matrix
Signal processing
analyte
analyte
 
Figure 1.3: Components of a biosensor. 
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In a biosensor, the biological recognition element is immobilized in the vicinity of the transducing 
element, which is known as functionalization. This immobilization can be done by physical entrapment of 
chemical attachment. Immobilized biological recognition element attracts specific target analyte, and the 
recognition event is converted into measurable signal via transducer. The transducer might then send the 
signal further signal processing unit. 
 
Bioreceptor Transducer
Analyte No 
Recognition 
signal
Bioreceptor Transducer
Analyte
Recognition 
signal
 
Figure 1.4: Specific recognition using biological recognition element is the basic of biosensor. 
 
Sensitivity and selectivity are the two most important performance factors in a biosensor. A biosensor 
must be selective enough to ensure specific detection, as well as highly sensitive to convert the 
biorecognition event into useful measurable signal. The selectivity is ensured by using proper 
bioreceptors for functionalization, while sensitivity largely depends on the choice of device type used.  
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1.4 Research Objectives 
As described in the previous sections, a suitable, robust, sensitive biosensor platform that can be used for 
multiple biomolecules can go a long way in the fairly untapped biosensor market. This work investigates 
the prospect of AlGaN/GaN HEMT as a biosensor in comparison with two other types of biosensor 
platform, namely nanofiber based biosensors and cantilever based biosensors. The superiority of the 
HEMT based biosensors over the other two types has been demonstrated. A physics based model to 
predict the behavior of the proposed bioFET is proposed to be developed. The model is validated using 
experimental data. The existing models of AlGaN/GaN HEMT found in the literature [3, 4] can be also be 
improved by considering the effects of polarization which serves as the key mechanism to induce the 
carriers in AlGaN/GaN HEMT devices. The physics based model is then modified for floating gate 
configuration to predict the behavior of the proposed HEMT based biosensor platform. 
 
1.5 Outline of Dissertation 
The second chapter of the dissertation contains the literature review on the history and types of bioFET. 
Chapter 3 presents two biosensor platforms which have been physically realized, and their pros and cons. 
Chapter 4 describes the advantages of HEMT device as a bioFET along with experimental data. Chapter 5 
contains the charge control model of the proposed HEMT device, while chapter 6 describes the floating 
gate model of the device when configured as a bioFET. Original contributions and future work outlines 
are discussed in Chapter 7. 
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Chapter 2 
Literature Review 
2.1 Introduction 
Technological advancement heavily relies on the estimation, monitoring and control of relevant chemical 
species. A major portion of this intelligence is acquired via sophisticated central laboratories. Nonetheless 
portable, sensitive and readily available sensor platforms are required in many circumstances, especially 
in clinical applications, where timeliness in both testing and monitoring of analytical markers are critical 
for diagnosis of the disease and patient treatment.  
 
This chapter focuses to give a brief review of biosensor technology over the last five decades. Different 
types of biosensors, their desirable features and challenges that impede the advance in this field are also 
discussed.   
 
2.2 A Brief History of Biosensors 
L. C. Clark Jr., the father of the biosensor concept, first described a biosensor platform based on oxygen 
electrode in 1956 [5]. In 1962, he proposed an efficient method to make electrochemical sensors (pH, 
polarographic, potentiometric or conductometric) by introducing enzyme transducers as membrane 
enclosed sandwiches. The concept was illustrated by trapping glucose oxidase at a Clark oxygen electrode 
using dialysis membrane and observing the oxygen concentration level. The decrease in measured oxygen 
concentration was proportional to glucose concentration. Clark's glucose sensor was first launched as a 
commercial sensor in 1973. But it became a commercial success in 1975 with the re-launch of the Yellow 
Springs Instrument Company (Ohio) glucose analyzer based on the amperometric detection of hydrogen 
peroxide.   
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Guilbault and Montalvo [6] were the first to detail a potentiometric enzyme electrode. They described a 
urea sensor based on urease immobilized at an ammonium-selective liquid membrane electrode. The use 
of thermal transducers for biosensors was proposed in 1974 and the new devices were christened thermal 
enzyme probes [7] and enzyme thermistors by Mosbach [8], respectively. In 1975, Divis [9] suggested 
that bacteria could be harnessed as the biological element in microbial electrodes for the measurement of 
alcohol.   
 
Lübbers and Opitz [10] coined the term optode in 1975 to describe a fiber-optic sensor with immobilized 
indicator to measure carbon dioxide or oxygen. They extended the concept to make an optical biosensor 
for the continuous measurement of chemical concentrations in a biological system using a fiber-optic 
oxygen sensor [11]. Commercial optodes exhibit excellent performance for in vivo measurement of pH, 
pCO2 and pO2, but enzyme optodes were not yet widely available. In 1976, Clemens et al. [12] 
incorporated an electrochemical glucose biosensor in a bedside artificial pancreas and this was later 
marketed by Miles (Elkhart) as the Biostator. Although the Biostator is no longer commercially available, 
a new semi-continuous catheter-based blood glucose analyzer has recently been introduced by VIA 
Medical (San Diego). In the same year, La Roche (Switzerland) introduced the Lactate Analyzer LA 640 
in which the soluble mediator, hexacyanoferrate, was used to shuttle electrons from lactate dehydrogenase 
to an electrode. Although this was not a commercial success at the time, it turned out in retrospect to be 
an important forerunner of a new generation of mediated-biosensors and of lactate analyzers for sports 
and clinical applications. A major advance in the in vivo application of glucose biosensors was reported 
by Shichiri et al. [13] who described the first needle-type enzyme electrode for subcutaneous implantation 
in 1982. The idea of building direct immunosensors by fixing antibodies to a piezoelectric or 
potentiometric transducer had been explored since the early 70’s, but it was a paper by Liedberg et al. 
[14] that paved the way for commercial success. They described the use of surface plasmon resonance to 
monitor affinity reactions in real time. The BIAcore (Pharmacia, Sweden) launched in 1990 is based on 
this technology. In 1984, a method was described to use ferrocene and its derivatives as an immobilized 
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mediator for use with oxidoreductases [15] in the construction of inexpensive enzyme electrodes. This 
formed the basis for the screen-printed enzyme electrodes launched by MediSense (Cambridge, USA) in 
1987 with a pen-sized meter for home blood-glucose monitoring.  
Academic journals contain descriptions of a wide variety of devices exploiting enzymes, nucleic acids, 
cell receptors, antibodies and intact cells, in combination with electrochemical, optical, piezoelectric and 
thermometric transducers1, [16]. Within each permutation lies a myriad of alternative transduction 
strategies and each approach can be applied to numerous analytical problems in health care [17], food and 
drink [18], the process industries [19], environmental monitoring [20], defense and security. Generic 
goals may be identified which underpin more applied biosensor programs and tackle some of the principal 
hurdles to the more widespread adoption of biosensor technology for analysis. Design of integrated 
systems as well as approaches to patterning sensitive elements and methods for improving the sensitivity, 
stability and selectivity of the biosensors are the key areas of biosensor research. 
 
2.3 Different Types of Biosensors 
Biosensors comprise a combination of three building blocks: a biological or physiological system; 
instrumentation or sensing system; and an electrical and electronic system. The biological or 
physiological system refers to the preparation of the target analyte and modifying the sensor system for 
detection, the instrumentation or sensing system refers to the instrument, fitted with highly sensitive and 
accurate sensors, and the electrical and electronic system refers to the associate circuitry which manages 
the signal processing and the conversion to an analog/digital display. 
Based on this basic platform, a number of different technologies have been developed to construct 
biosensors, not all of which are used in all application types. Figure 2.1 describes the key biosensor 
technologies that are currently in use. Different biosensors exploit different inherent properties such as 
physical, chemical, electrical, mechanical or optical properties of the sensing material.  
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BioSensor Technologies
Electrochemical Bioluminescent Piezoelectric Resonant mirror Opto-electric Thermistor
Potentiometer Amperometric Conductometric
Surface Plasmon 
Resonance
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Frequency
Surface 
Transverse wave
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Acoustic Wave
 
Figure 2.1: Different types of biosensors. 
 
2.4 Desired Features of Biosensors 
2.4.1 Sensitivity 
Clinical applications, food technology and environment monitoring demand increased sensitivity and 
detection range for various analytes. While the precise demands to meet today’s requirements may be 
modest in these respects, the long term benefits of reliable detection of trace amounts of various 
indicators, additives or contaminants is uncontended. With the advent of atomic force microscopy, single 
molecule detection in the research laboratory is possible, but great strides have also been made with 
conventional sensors for the detection of the analytes of interest. Enzyme electrodes have been designed 
which preconcentrate the target analyte [21]. A gas-phase microbiosensor has been reported for phenol in 
which polyphenol oxidase was immobilized in a glycerol gel on an interdigitated microelectrode array 
[22]. Ultra-low detection limits are achievable with affinity sensors and electrochemical detection may be 
readily integrated with chromatographic techniques to yield user-friendly devices [23]. In an alternative 
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approach, double-stranded DNA may be used as a receptor element. "Sandwich"-type biosensors based 
on liquid-crystalline dispersions formed from DNA-polycation complexes may find application in the 
determination of a range of compounds and physical factors that affect the ability of a given polycation 
molecule to maintain intermolecular crosslinks between neighboring DNA molecules [24].  
 
2.4.2 Stability 
The most obvious disadvantage in exploiting the exquisite specificity and the sensitivity of complex 
biological molecules is their inherent instability. Many strategies may be employed to restrain or modify 
the structure of biological receptors to enhance their longevity. The effectiveness of sol-gels as an 
immobilization matrix in an optode for glucose to enhance the stability of the glucose oxidase catalyst has 
been demonstrated [25]. Some desirable activities, however, remain beyond the reach of the current 
technology.  
 
2.4.3 Selectivity 
The selectivity of the biosensors can be improved by adopting two different methods; the interface 
between the transducer and the biological receptor may be made more exclusive thus reducing 
interference, and new receptors can be developed with improved or new affinities. The use of mediators 
as a strategy to improve performance in amperometric biosensors has also been proved extremely 
popular. Alternatively, electrocatalytic detection of the products of enzymatic reactions may be enhanced 
by the use of chemically modified electrodes such as rhodinised [26] or hexacyanoferrate-modified [27] 
carbon. Arguably a more elegant solution is to seek connection of the redox center of an enzyme to an 
electrode via a molecular wire. Much has been published about these "wired" enzymes, but the literature 
has generally been concerned with immobilized mediators on various polymer backbones. Novel 
heteroarene oligomers, consisting of two pyridinium groups, linked by thiophene units of variable length 
(thienoviologens) are promising candidates for such conducting molecular wires and may be used in 
conjunction with self-assembly techniques to produce an insulated electrode which transfers electrons 
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specifically along predetermined molecular paths [28]. This design should produce enzyme electrodes 
free from electrochemical interference. Advances in computational techniques now allow us to model 
both electron transfer reactions and receptor binding interactions with increasing accuracy. This not only 
enhances our understanding of the receptor/transducer interface, but allows us to consider designing new 
receptors based on biological molecules.  
 
2.5 Challenges in Biosensor Technology 
In spite of a number of innovative biosensors developed to date, the biosensors market is still far from 
meeting some of the key end-user needs. The key features that are yet to be implented include: 
 development of biosensors capable of multitest detection and monitoring 
 development of integrated biosensing platforms 
 development of a self-configuring biosensor 
 complete multiproduct, multivendor interoperability among biosensors 
 migration to lab-on-chip biosensors 
 availability of wireless options 
There are various issues that hinder the growth of biosensor technology. To begin with, the lifespan of a 
biomolecule is usually limited which calls for rapid detection. The readout time greatly varies from one 
biosensor to another. In certain cases, the readout time can be as long as 20 seconds.  Most biosensor 
requires chemical pre-treatment prior to any kind of detection, which slows down the detection process. 
Long term stability and miniaturization issues of the sensors still remain unsolved, which in term reduces 
the cost-effectiveness of the sensors for commercial applications. Moreover, most biosensing techniques 
require bulky optical instruments which are not suitable for point of care applications. Rugged biosensors 
that can work in extreme environments to monitor vital signs also have limited availability. 
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Considering all these technical challenges, it can be concluded that there is a great need for a portable, 
miniature, robust, sensitive biosensor platform. 
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Chapter 3 
Electrode and Transistor Based Biosensor Platforms 
3.1 Introduction 
Biosensors were first developed based on electrode conduction principle. As such, most commercial 
biosensors found to date are also based on the similar technique. But to reap the benefits of inherent gain 
of transistors and to provide easy integration with data processing circuitry, transistor based biosensors 
are gaining more popularity nowadays. This chapter gives a description of two different types of 
biosensor platforms that has been tried with their working principle and experimental data collected. The 
first type is based on electrode conduction, where carbon nanofibers are used as electrodes. The second 
type is cantilever based, where the microcantilever at the base of a transistor is used for detection and the 
advantages of a transistor based system is also utilized. 
 
3.2 Glucose Sensor Based on Vertically Aligned Carbon Nanofibers 
Carbon electrodes have been proven successful when used as enzymatic biosensors in terms of wide 
range of functionality and cost effectiveness. Among the carbon electrodes carbon nanostructures 
(cylindrical or conical structures) demonstrate the best potential. These carbon nanostructures have 
diameters varying from a few nanometers to hundreds of nanometers and lengths ranging from less than a 
micron to a few millimeters [29]. Although  carbon nanotubes (CNTs) have been widely used in 
biosensor research, carbon nanofibers (CNFs)are emerging as a potential candidate to replace CNTs. 
CNFs have excellent conductive and structural properties comparable with CNTs that make them 
excellent candidates as electrodes as well as immobilizing substrates[30], [31]. CNTs and CNFs can be 
used as electron field-emission sources, electrochemical probes, functionalized sensor elements, scanning 
probe microscopy tips, hydrogen and charge storage devices, catalyst support, and nanoelectromechanical 
systems (NEMS). Only the tips of the CNTs are active owing to their extremely regular shapes. In 
contrast, a CNF has many irregularities and defect sites with exposed carboxyl groups throughout their 
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surfaces, which serve as excellent locations for electrochemical charge transfer [32]. These result in better 
sensitivity and responsiveness in the CNFs compared to the CNTs [33]. Because of superior structural 
properties the CNFs also have better mechanical stability than the CNTs [34].  
 
Because of the clinical significance, substantial research and development efforts have been devoted to 
the development of reliable glucose sensors. Most of the proposed glucose sensors rely on amperometric 
enzyme electrodes based on glucose oxidase (GOx).Oxidase based biosensors depend on the 
immobilization of the oxidase enzymes and the co-enzymes on the surface of the electrodes and the 
subsequent detection of the current associated with the redox product in the biological reaction. Mediator 
based glucose sensors are also proposed in literature where artificial mediators and permselective coatings 
are introduced in biosensor fabrication to increase the selectivity and the sensitivity of the amperometric 
biosensors [35, 36]. Use of some of the mediators is limited by stability and toxicity while the 
permselective membranes show effective but incomplete rejection [37, 38]. 
 
An attractive way to improve the performance of the glucose sensor is to use an enzyme wiring technique. 
Enzyme wiring improves the electrical contact between the redox center of the electrode surfaces and 
glucose oxidase (GOx) [39]. Due to similar dimensions of the nanoparticles and the redox proteins such 
nanomaterials can be used for effective electrical wiring of redox enzymes. Various types of 
nanomaterials such as gold nanoparticles [40], carbon nanotubes (CNT) [41] have been used as electrical 
connectors between the electrodes and the redox centers of the GOx. Carbon nanotubes (CNT) can be 
coupled to the enzymes to provide a favorable surface orientation and can act as an electrical connector 
between their redox centers and the electrode surfaces. Patolsky et al. demonstrated that the aligned 
reconstituted GOx on the edge of the single-wall carbon nanotubes (SWCNT) can be linked to an 
electrode surface [41]. Various glucose biosensors based on CNT have been proposed taking the 
advantage of this excellent property of ‘plugging’ of the electrode with GOx [42], [43]. Due to their 
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superior sensitivity compared to CNTs, VACNFs can be easily used to build glucose biosensors based on 
this enzyme wiring technique.  
 
3.2.1 Working Principle 
In general the oxidase-based biosensors depend on the immobilization of oxidase enzymes and co-
enzymes on the surface of the electrodes and the subsequent detection of the current associated with the 
redox product in the biological reaction. Total workflow of the proposed glucose biosensor system is 
shown in Figure 3.1.  
 
Silicon substrate
Chromium electrode
Oxide coating
VACNF electrode
Enzyme wiring / Electrode plugging
Glucose oxidase 
(GOx) and 
Horseradish  
peroxidase (HRP)
 
 
Figure 3.1: A cross sectional view of the fabricated VACNF based biosensor. The biosensor is prepared by co-
immobilization of HRP and GOx on the VACNF surface. Chromium electrode was plugged with the GOx through 
VACNF by the enzyme wiring technique. 
 
 
Initially GOx functions as an enzyme and binds the β-D-glucose on the VACNF/HRP/GOx electrode 
surface. Next the GOx catalyzes the oxidation process and transform β -D-glucose to D-glucono-1, 5-
lactone, which is then hydrolyzed to gluconic acid: 
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Glucose + O2 
GOx Gluconic Acid + H2O2       (3.1) 
The reduction process corresponds to the electrocatalytic reduction of hydrogen peroxide (H2O2) by the 
co-enzyme horseradish peroxidase (HRP) (equations 3.2 – 3.4) [43, 44]. The reduction reaction can be 
shown as: 
OHeHOH HRP 222 222 
      (3.2) 
This reduction reaction can be divided into two reactions where HRP actively catalyzes the process [43, 
44]: 
OHIcompoundOHFeHRP 222
3 _)(                 (3.3) 
OHFeHRPHeIcompound 2
3 )(22_         (3.4) 
 
Hydrogen peroxide (H2O2) resulting in this process is used for the reduction reaction. HRP is a co-enzyme 
which has accessible active sites. As a result the electron donors and the acceptors can participate in the 
reaction where HRP plays the role of a catalyst. The reduction process corresponds to the electrocatalytic 
reduction of H2O2 by HRP produced by the oxidation process (see equations 2 - 4). Electrons required for 
the reduction process are supplied externally by the Cr electrode via VACNFs to the reaction centers. If 
the current associated with the flow of electrons due to the redox reactions can be measured, it can 
directly be correlated with the amount of glucose present in the biosensor system. Thus glucose detection 
is possible by measuring the reduction current only. 
 
3.2.2 Experimental Setup 
A bienzymatic biosensor is prepared by co-immobilizing HRP and GOx on the VACNF surface. To 
confine the chemicals to the area of interest, a well is formed around the nanofiber forests. The amounts 
of HRP and GOx are chosen in such a way that they can cover the entire surface area of the VACNF 
forest. Then the entire sensor chip is dried using a vacuum pump. When not in use all the modified 
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electrodes are stored at 4°C in phosphate buffer saline (PBS). The Cr electrode was plugged with the GOx 
through the VACNF via enzyme wiring technique to facilitate an efficient way to transfer electrons from 
the electrode to the reaction centers. A CHI 666A electrochemical analyzer was used for measurement. 
The tungsten working electrode (cathode) was connected to the VACNF and the tungsten reference 
electrode (anode) and the counter electrode were connected to the solution, as shown in Figure 3.2. 
 
 
Figure 3.2: Test setup for the glucose sensor using VACNF electrode. 
 
3.2.3 Results and Discussion 
Figure 3.3 represents the amperometric response of the VACNF/HRP/GOx glucose sensor. In the absence 
of glucose, application of a potential between the electrodes results in a current flow between them. 
Addition of glucose to the system induces a flow of reduction electrons, which opposes the initial flow of 
current. This is represented by the overall decrease in measured current. This result is similar to the result 
reported by Wu et al. [38]. 
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Figure 3.3: Amperometric response of VACNF/HRP/GOx biosensor in 0.1 M pH 7.4 PBS in the addition of 4 mM 
glucose. The biosensor responded immediately with the addition of glucose. Initial potential was set to -0.4 V. 
 
3.3 Anthrax Sensor Based on Microcantilever 
Microorganisms have been in existence for billions of years and their importance in environmental 
processes and human activities is well recognized. Certain bacteria, notably those of the Bacillus and 
Clostridium groups, differentiate spores that are highly resistant to chemical and physical insults. Spores 
of these certain species demonstrate persistent attachment to inert and negatively charged surfaces. 
Development of a lightweight and spore-specific sensor is very useful for early detection of the presence 
of bacterial spores. 
 
Biomolecule detection can be achieved by the immobilization of biomolecules on a chemically treated 
cantilever which affects the performance of the embedded MOSFET. Targeted binding of the biomolecule 
generates stress on the cantilever which creates interface defects and traps in the channel region of the 
embedded MOSFET, thereby reducing mobility. Different designs including the orientation of the 
cantilevers with respect to the embedded MOSFET have been adopted to maximize the stress effects on 
the characteristics of the MOSFET [46].  
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3.3.1 Working Principle 
For the cantilever along the transversal direction of the current flow in the MOSFET [47], the transverse 
tensile stress dominates the compressive longitudinal stress.  The change in the channel resistance due to 
the applied stress can be written as [46],    
lltt
R
R
 

 
Here the subscripts t and l stand for transverse and longitudinal directions, respectively. The combined 
effect of the variations of the piezoresistive coefficients (-πt, +πl) and the stress components (-σt, +σl) in 
the cantilever due to the adsorption of target molecules results in increased channel resistance (reduced 
mobility) and therefore reduced drain current. Overall, the embedded structure shows high sensitivity (1-2 
μA/nm) enabling the detection of 5 to 10 nm deflections of the cantilever [47]. 
 
3.3.2 Experimental Setup 
Microcantilevers are fabricated as arrays, where cantilevers of SiNx and SiNx with thin gold coated layer 
are placed in an alternating fashion. The embedded MOSFETs are located at the base of the cantilevers 
where stress due to adsorption is the maximum.  
 
 
Figure 3.4: SEM image of two identical cantilevers displaying embedded MOSFET and geometry of the gold-
coated and SiNx cantilever beam pair [47].  
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For microbial sensor a MOSFET at the base of a SiNx microcantilever works as the reference whereas a 
MOSFET at the base of a SiNx microcantilever with a thin coating of gold is used as the probe as shown 
in Figure 3.4. The differential drain current between the probe and the reference microcantilevers, which 
further minimizes systematic noise and environmental perturbations, forms the basis for the anthrax 
simulant detection due to selective adsorption to the gold-coated probe. 
 
For the experiments, the MOSFET-embedded microcantilevers were first characterized to obtain the drain 
current versus the drain-to-source voltage curves to be used as reference as shown in Figure 3.4. Then, 
both the bare SiNx and the gold-coated cantilevers were submerged in a phosphate buffer solution (PBS) 
to chemically treat the cantilevers for anthrax simulant attachment. Effect of the buffer solution 
application was observed by taking the characteristic curves of both MOSFETs. Afterwards 15µL of 
anthrax simulant solution (suspension population of 1.3 x 107 Colony Forming Unit/ml diluted in 40% 
ethanol and 60% de-ionized water) was applied over the cantilever MOS pairs in doses of 5µL. 
Characteristic curves were obtained after each dose application. Under the microscope the bending of the 
gold-coated cantilever was clearly visible whereas the silicon nitride cantilever remained unaffected. It 
was noticed that the anthrax simulant spores were attracted to the voltage supplying probes when voltage 
was applied to obtain characteristic curves. Signatone Checkmate probe station and HP 4155B parameter 
analyzer were used for collecting the measurement data. 
 
3.3.3 Results and Discussion 
Before the application of phosphate buffer solution (PBS) both the SiNx and gold-coated cantilever MOS 
structures demonstrate similar characteristic curve as shown in Figure 3.5a. Application of PBS causes the 
gold cantilever to bend as it gets attached to the gold surface while SiNx cantilever remains unbent. The 
effect of applying PBS on the MOSFET drain current, as one cantilever bends and the other remains 
unbent is shown in Figure 3.5b. 
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(a) 
  
(b) 
Figure 3.5: a) Characteristic curves of SiNx and gold coated cantilever MOS at applied gate voltage of VG = 5V, b) 
responses of Au and SiNx MOSFETs with VG = 5V in buffer solution. 
 
Due to selective adsorption, anthrax stimulant adhere to only the gold-coated cantilevers and probe 
MOSFET experiences stress and subsequent drain current reduction phenomenon. SiNx cantilevers do not 
adhere to biomolecules, therefore the reference MOSFET do not show any change in current. 
 
3.4 Conclusion 
Although both the VACNF and microcantilever based sensors provide promising results, they fail to 
provide for the demands of the rugged, simplistic biosensors that can be commercialized, at least at their 
current state of development. Nanofiber based sensors require complex imprint technology, and the 
integration with CMOS circuitry is also difficult. Microcantilever based sensors can utilize the benefits of 
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transistor based systems and can be readily integrated with CMOS circuitry for signal processing, but 
they lack mechanical stability and thus cannot be used for high concentration biomolecule samples. The 
target biomolecules must be diluted, thereby requiring an extra step in the sensing process. Also, since 
they use strain on the cantilever, they are more susceptible to give a false alarm if some dust or unwanted 
particles falls on the cantilevers. As such, there still remains the need for a truly transistor based system 
where the biomolecules will interact with the sensor electrically. 
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Chapter 4 
High Electron Mobility Transistor as BioFET Platform 
4.1 Introduction 
In this chapter, the advantages of AlGaN/GaN high electron mobility transistor (HEMT) as a bioFET are 
explained. While compared to the biosensor platforms presented in chapter 3, the HEMT based biosensor 
platforms demonstrate chemical and surface stability, high sensitivity towards surface charge phenomena 
to become the ultimate choice. Two different types of biomolecules, one from plant (photosystem I, or PS 
I) and one from human body (Human Monokine induced Interferron Gamma, or human MIG) are 
detected by the HEMT devices configured as biosensor. The experimental data shows excellent promise 
to differentiate between the presence and absence of target biomolecules.   
 
4.2 HEMT Structure 
Of the various device FET structures, HEMT devices show better performance as high-power and high-
frequency devices. Capacitive modulation of the channel charges is the basic principle of operation for all 
the FET devices. With this common concept, use of different geometries, different materials and doping 
profiles results in the variety of FET transistors. Eventually, each type of FET would differ in the 
confinement of the channel charges and the isolation between the gate and the channel, which would 
result in a novel device with specific properties. The first HEMT was based on GaAs/AlGaAs 
superlattices pioneered by L. Esaki and R. Tsu at IBM in the late 1960’s [48]. They proposed that by 
modulation doping, a process where electrons are transferred from highly doped and wider bandgap 
material (AlGaAs) to a lightly doped material (GaAs), high mobilities in GaAs is achieved [48]. R. 
Dingle, H. L. Stormer, A. C. Gossard, and W. Wiegmann of AT&T Bell Labs, working independently, 
demonstrated high mobilities in a GaAs-AlGaAs superlattice in 1978. Realizing the high performance 
capability of such a structure of the field-effect transistor, researchers of various labs in the United States 
(Bell Labs, University of Illinois, and Rockwell), and Japan (Fujitsu), and France (Thomson CSF) started 
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working on this device. In 1980, the University of Illinois and Rockwell first fabricated such a device 
with a reasonable microwave performance, which they named as modulation-doped FET or MODFET. 
The same year researchers at Fujitsu reported the results for a device with a 400-pm gate. They called the 
device “high electron mobility transistor” or HEMT. Thereafter, Thomson CSF and Bell Labs followed 
calling their realizations a “two-dimensional electron gas FET” or TEGFET, and “selectively doped 
heterojunction transistor” or SDHT, respectively [48]. 
 
In conventional metal-semiconductor FET’s (MESFET’s), the donor impurities generate the electrons 
(carriers) and reside in the same space/layer with the electrons. As a result, the conducting electrons start 
colliding with the impurities. For higher speed, more current is required which necessitates larger 
concentration of electrons. This leads to more electron-donor interaction, called ionized impurity 
scattering. 
 
In addition, thinner channel layers and higher electron concentrations are required for smaller FET size. 
The isolation of large electron concentration with donors can be obtained by employing heterojunctions. 
A heterojunction is formed between two different bandgap materials such as AlGaAs and GaAs. The 
donors are introduced only into the larger bandgap (AlGaAs) material [49], [50]. The electrons originally 
introduced into the larger bandgap layer (AlGaAs) diffuse to the lower energy (GaAs) layer where they 
remain confined due to the energy barrier at the heterointerface as illustrated by the band diagram in 
Figure 4.1.  
 
Thus, a 2-dimensional electron gas (2-DEG) is formed at the heterointerface very close to the gate, which 
leads to very high electron mobilities and large electron velocities at very small values of drain voltage 
[51]. 
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Figure 4.1: (a) Schematic diagram of an AlGaAs/GaAs HEMT structure, (b) Energy band diagram of the HEMT 
device showing the formation of the 2 dimensional electron gas in the quantum well. 
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In 1993, Asif Khan et al. first demonstrated a HEMT based on AlGaN and GaN heterojunctions [52]. 
Since then much progress has been made for the achievement of better performances of AlGaN/GaN 
HEMT. AlGaN/GaN exhibits improved ratings for power and frequency applications compared to 
AlGaAs/GaAs HEMT. This is due to the superior intrinsic properties of GaN material compared to GaAs 
as evident from Table 4.1 and also due to the polarization effects dominant in AlGaN and GaN materials.  
 
Table 4.1 
Comparison of Different Semiconductor Materials 
Semi- 
Conductor 
E
g
 
(eV) 
µ 
(cm
2
/ 
V-sec) 
ε
r
 E
c
 
(kV/ 
cm) 
v
s
 
(10
7 
x 
cm/sec) 
λ 
(W/cm-
K) 
T
max 
(
o
C) 
Si 1.1 1300 11.4 300 1 1.5 300 
GaAs 1.4 5000 13.1 400 1 0.46 300 
SiC 2.9 260 9.7 2500 2 1.49 600 
GaN 3.4 1500 9.5 2000 2.2 1.3 700 
 
GaN has both Zincblende nad Wurtzite crystalline forms. It is normally grown on the Ga-face, along its c-
axis. It has a substantial spontaneous electrical polarization perpendicular to the hexagonal plane, and in 
the direction down into the Ga-face surface. When AlxGa1-xN is grown on GaN, larger electrical 
polarization results in the same direction. AlxGa1-xN has a smaller lattice constant, so that the two-
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dimensional tension causes a piezoelectric effect which adds to the spontaneous polarization [53]. A 
positive sheet charge density appears due to the net polarization effect, which causes an accumulation of 
electrons at the interface and thus forms the 2-DEG as shown in Figure 4.2. Thus, even without any 
intentional doping in the AlGaN layer, a high charge density channel is formed at the heterointerface. 
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DrainSource
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20 nm
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Figure 4.2: AlGaN/GaN HEMT structure and the formation of 2DEG. 
 
4.3 Advantages of AlGaN/GaN HEMT as a BioFET 
The AlGaN/GaN high electron mobility transistor (HEMT) devices are focus of increasing interest as 
biologically modified field effect transistor (BioFET) based micro- and nano-electronic sensor platforms 
in recent years. They excel over their counterparts because of their inherent properties such as: (i) 
chemically stable bulk and surface properties, (ii) a high-density two-dimensional electron gas (2DEG) 
available at the hetero-interface which allows a highly sensitive detection of surface-charge related 
phenomena, and (iii) as a piezoelectric material, its conductivity changes upon a change of the surface 
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charge, such as that due to binding of antigen onto an antibody-functionalized surface11. These very 
favorable material attributes significantly facilitate amplification of the current change pertinent to change 
in the gate potential due to the proximity of the immobilized biomolecules and/or biomolecular binding 
events between the charged biological molecules (e.g., antigen-antibody or receptor-analyte binding 
events) at the high charge density sensing channel or the gate surface [54,55]. 
 
4.4 Experiments 
4.4.1 Photosystem I 
PS I reaction centers are potential sources of solar energy. Using sunlight, these reaction centers generate 
electrical potentials which can be accumulated to build substantial source of electrical energy if proper 
extraction technique can be developed. In oxygenic plants there are two types of reaction centers – 
Photosystem I (PS I) and Photosystem II (PS II). Both of the reaction centers work in succession to 
produce glucose for green plants, some bacteria and protists in photosynthesis. Photosynthesis is a two 
phase process. The first phase is light dependent which requires direct energy of light to produce energy 
carrier molecules. The second phase is light independent. During the first phase, light energy induces 
electron separation in PS II. PS II fills the electron from a water molecule, breaking the water into H+ ions 
and O-2 ions. These O-2 ions combine to form O2 molecule. The electron is boosted to a higher energy 
state and finally transferred to PS I through electron acceptor and a series of redox reactions. The electron 
is again passed through a series of redox reactions and eventually becomes attached to NADP+ and H+ to 
form NADPH, which is the energy carrier in the light independent reaction. There is thus a continuous 
flow of electrons from water to NADPH, which is used for carbon fixation in the light independent 
process. Thus, PS I and PS II work as energy harvesting units in photosynthesis.  
 
PS I RC/core antenna complexes containing about 40 chlorophylls per photoactive reaction center 
pigment (P700) can be isolated efficiently from thylakoids of plant leaves (such as spinach) using the 
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technique of detergent solubilization and hydroxylapatite column purification [56]. The isolated PS I 
complexes are elliptical in shape with major and minor axes of about 6 and 5 nm, respectively [56]. 
 
 
Figure 4.3: Charge separation in PS I due to absorption of light. 
 
The structure and the function of PSI reaction centers are schematically illustrated in Figure 4.3. An 
isolated PS I complex contains photochemical charge center of P700 and electron acceptors of A0, A1, FX 
and FAB. These electron acceptors serve as an antenna to capture photons and transfer photon energy to 
P700.The light energy triggers photochemical charge separation in P700 creating P700+ and A0
− within 
about 1.5ps [57].The electron released from P700 is transferred through intermediate acceptors A0, A1, Fx, 
to the terminal acceptor FAB at the reducing side of the PS I. Due to efficient excitation transfer and 
trapping, the entire photophysical chemistry can be completed in 10-30 ps. The quantum yield of PS I 
photochemistry is very close to 100%. Charge separation in this natural photovoltaic device generates a 
potential difference of about 1 volt across about 6 nm dimension between the reduced (FAB
− ) and the 
P700
+
A0
A1
FX
FAB
-
e
-
~ 6 nm
~ 1 V
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oxidized (P700+) sides of the PS I complex, resulting in a very strong electric field (~ –108 volts per 
meter). 
 
4.4.1.1 Functionalization of the BioFET 
Organic SAMs on solid surfaces are one of the most suitable functional linkage-layers for the 
immobilization of biomolecular complexes.  To date, the SAMs of alkanethiols on Au surfaces are the 
most intensively studied immobilizing systems. Functional PS I RCs can be selectively immobilized and 
oriented by the chemical modification of the Au surface [56].  Two-dimensional vectorial arrays of 
functional PS I RCs have been prepared on atomically flat derivatized Au surfaces [56].  The atomically 
flat Au {111} substrate were treated with mercaptoacetic acid (HSCH2COOH), 2-
dimethylaminoethanethiol [(CH3)2NCH2CH2SH], and 2-mercaptoethanol (HSCH2CH2OH) which form a 
negative, positive, and hydrophilic surfaces, respectively. Then the substrates were incubated in PS I 
solution and it was found that 65% of the area was covered with PS I when treated with mercaptoacetic 
acid. The negatively charged end groups attract and orient PS I RCs on the substrate.  Previous studies 
have shown that the polar regions (both ends) of the PS I are positively charged [56].  These regions serve 
as the docking sites for ferredoxin and plastocyanin, the natural electron acceptor and donor, respectively, 
for PS I.  On the other hand, very little PS I coverage was found (5.0%) on 2-dimethylaminoethanethiol 
treated Au surface terminated with positively charged end groups [56]. When treated with 2-
mercaptoethanol, 70% of the area was covered with PS I. The treatment with 2-mercaptoethanol 
terminates the surface with end groups that form hydrogen bonds with PS I arrays. 
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Figure 4.4: Orientation of PS I molecules after treating the gate with Marcaptoacetic acid and 2-Marcaptoethanol. 
 
In addition, PS I can be selectively oriented by the modification of a surface with the specific 
organosulfur compounds/thiols [56].    For mercaptoacetic acid, 83% of the electron transport vectors 
were found parallel to the surface, whereas with 2-mercaptoethanol 70% were oriented perpendicularly in 
the “up” position with P700 facing the Au surface and only 2% were in the “down” position (Figure 4.4). 
No preferential orientation was observed with 2-dimethylaminoethanethiol. 
 
4.4.1.2 Experimental Setup 
The surface of the AlGaN/GaN HEMT was treated with 2-mercaptoethanol to functionalize the PS I RCs. 
After waiting for 30 seconds, the die was immersed in PS I solution and was kept in refrigerator for 24 
hours. The DC current-voltage (I-V) characteristics have been measured by a Signatone Checkmate DC 
probe station and a Keithley 2400 source meter. The measurements have been performed in floating gate 
configuration, i.e., without any applied gate bias. The test conditions were kept identical before and after 
the immobilization of RCs and as well as in the dark and in the light environments. A Labview program 
was developed to measure the current-voltage characteristics in all conditions. The floating gate test set-
up is shown in Figure 4.5. 
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Figure 4.5: Test setup used for the measurement purpose using Signatone Checkmate probe station. The devices are 
configured in floating gate configuration, as can be seen above. 
 
4.4.1.3 Test Results and Interpretation 
The measured I-V characteristics of the HEMT device are shown in Figure 4.6. The drain current before 
and after the immobilization of the PS I RCs is measured in both light and dark environments. Figure 4.6b 
shows drain current after immobilizing PS I RCs before and after illumination. The net change in the light 
and the dark characteristics of the HEMT due to the immobilization of PS I RCs on the gate is also shown 
in Figure 4.6b. The charge separation mechanism due to light and the resultant changes in the drain 
current are explained in Figure 4.7. 
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(a) 
 
(b) 
Figure 4.6: (a) Measured I-V characteristics before and after the immobilization of PS I in light and dark 
environment, (b) Changes in the I-V characteristics of the device as a result of PS I immobilization and charge 
separation in PS I RC under illumination. 
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The orientation for most of the reaction centers on the 2-mercaptoethanol treated surface can be 
determined by noticing the changes in the current directions due to PS I immobilization. As reported in 
[56], 70-80% of PS I molecules on 2-mercaptoethanol-modified Au surfaces are oriented primarily with 
the electron acceptor side (FAB) up and the donor side (P700) down (adjacent to the 2-mercaptoethanol-
modified gate surface).  
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(b) 
Figure 4.7: Conceptual illustration of the effect of the dipolar nature of the RCs on the threshold voltage of the 
HEMT device with immobilized PS I in (a) dark and (b) under light environment. 
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Under illumination, the electric potential on the oxidizing side (P700) of PS I results in a positive voltage 
following electron release, whereas in the dark the potential is negative with respect to the substrate [58]. 
Therefore, each of the reactions centers in the dark can be modeled as a dipole with negative terminal 
near the substrate which in effect increases the threshold voltage of the HEMT and reduces the current 
(Figure 4.7a).  The current for PS I in dark is negative. Figure 4.6b is plotted by taking the magnitudes of 
all three currents. 
Under illumination, the current should have been reversed completely because of the inversion of dipole 
polarities (Figure 4.7b). However, during measurement a percentage of the reaction centers become 
denatured due to the oxygen in the atmosphere, and refrains the current from completely reversing its 
direction. Figure 4.6a shows the net current of the HEMT in the presence of PS I under illumination. 
Therefore, the difference in the light and the dark currents due to PS I provides a measure of the current 
for charge separation across the photoactive reaction centers. The resulting current due to photon induced 
redox process in the reaction centers is also shown in Figure 4.6b. 
 
4.4.2 Human Monokine Induced Interferron Gamma 
Although, organ and tissue transplantation is an increasingly important patient treatment option in a 
number of disease conditions (for example, kidney, liver, skin, heart, etc.), the rate of allograft rejection 
episodes is still quite high, occurring in approximately 20% of the recipients [59]. Thus, rejection of 
transplanted organs or tissues constitutes impedance to the successful long-term treatment of some of the 
disease conditions. Chemokines are a family of cytokines that have been shown to be crucial mediators of 
immune reactions leading to transplant or allograft rejection [59]. Specifically, evidence from various 
studies have clearly shown monokine induced by interferon-gamma (MIG/CXCL9) as playing a central 
role among the chemokine proteins implicated in rejection of heart, skin and kidney tissue allografts. 
MIG, a member of the CXC subfamily of chemokines is an inflammatory chemokine that play an 
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important role in cell activation, and is produced during T-cell-mediated responses to inflammation 
including allograft rejection episodes) [60,61]. Consequently, MIG is investigated as a target immune 
response biomarker in transplant applications [60, 62, 63]. The range of MIG concentration in normal and 
pathophysiological disease states (including allograft rejection episodes) in humans is ≈ 0.2-3 ng/mL and 
10-400 ng/mL, respectively [64]. Due to the important role of MIG as a biomarker in transplant rejection, 
there is a great need to develop biosensor technology platforms to sensitively detect MIG for early 
monitoring of possible transplant rejection. 
 
4.4.2.1 Functionalization of the BioFET 
The sensing gate channel of the HEMTs have gold contact deposition, which is suitable for creating self-
assembled monolayers (SAMs) to immobilize the biomolecules. The self-assembly method for anchoring 
of the biorecognition molecules have a number of advantages relative to other approaches, namely, high 
reproducibility, molecular level control, vicinity from the surface, allowing direct electron/charge 
transfer[65]. Dithiobis(succinimidyl propionate) or DSP is a water insoluble, homobifunctional N-
hydroxysuccinimide (NHS) ester that can form a self-assembled monolayer on a gold surface due to its 
disulphide group [66]. The NHS group has primary amines as principle targets; consequently it has found 
applications for the immobilization of biomolecular species (proteins, etc) containing primary amines to 
gold surface [67]. The bisymmetrical DSP links to ε-amine groups on the α-amine position of N-terminal 
amino acids. The succinimidyl ester of DSP is an ideal leaving group to electron donating primary 
amines. Attack occurs at the electron deficient carbon of the ester on DSP by a primary amine to create an 
amide bond in suitable pH range for the covalent immobilization of the protein on the gold surface. The 
great advantage of building DSP SAMs in comparison to conventional methods [68, 69] is the elimination 
of the chemical activation step in the covalent attachment of biomolecules containing primary amines to 
create an amide bond (Figure 4.8). 
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Figure 4.8: Schematic illustrating the formation of reactive DSP SAM on HEMT gold gate for covalent 
immobilization of anti-MIG monoclonal IgG.  
 
The vicinity of short DSP SAMs from the electrode surface has been used previously to obtain direct 
electron transfer from redox copper centers [70]; DSP has spacer arm length of 12.0 Å or 8 atoms [71]. 
The short height of the SAM and the elimination of additional layers of chemical activating groups are 
advantageous for FET sensing architectures where proximity of the binding antibody-antigen pairs to the 
sensing gate surface is crucial for sensitive detection of the binding event. 
 
4.4.2.2 Experimental Setup 
Prior to any experimental work, the device was properly cleaned with acetone and ethanol and dried in 
nitrogen flow. To create the SAM layer, the gold gate region was exposed to 1 mM solution of DSP for 
two hours at room temperature. To remove the weakly absorbed DSP, the device was again washed away 
using acetone. The reactive SAM layer created covalently binds the anti-MIG monoclonal IgG molecules 
through their primary amine groups. To achieve immobilization, the gate was exposed to 25µL anti-MIG 
1gG in phosphate buffered saline (PBS) at 40C for 24 hours. Rinsing the device with Tween 20 solution 
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in PBS washes away the weakly bound anti-MIG. The change in the drain current due to the 
immobilization of the anti-MIG was measured. The resulting molecular affinity interface IgG receptors 
are then used for the binding and detection of the MIG. To accomplish this, the biofunctionalized gate 
was exposed to 20 ng/mL human MIG in PBS (150 mM) and the change in drain current due to the anti-
MIG/MIG binding interaction was measured. The volume applied is 25µL. Similar measurement was also 
carried out separately for 50 ng/mL MIG concentration. Before repeating the experiment with the same 
device, it was properly cleaned to eliminate any trace of analyte from the previous experiments. The step 
by step procedure is shown in Figure 4.9. 
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Figure 4.9: Step by step procedure for testing using GaN/AlGaN biosensor. 
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4.4.2.3 Test Results and Interpretation 
After the formation of SAM layer, the device current was a little lower compared to that of the clean 
device. This slight decrease in current may be due to the change in the gate surface after the SAM layer 
was created. However, exposure to anti-MIG IgG changed the drain current significantly. The anti-MIG 
molecules immobilized on the gate surface of the device impart specific biorecognition properties to the 
HEMT BioFET sensor. As it has been reported that antigens elicit antibodies of opposite charge and that 
the antigen-binding sites dominate the interface properties of IgG antibodies [72, 73], it is assumed that 
the positive polarity of the anti-MIG IgG molecules lies adjacent to the gate surface. 
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Figure 4.10: Increase in drain current after anti-MIG immobilization on gate. 
 
Each positive charge on the gate surface induces a negative charge in the 2DEG due to capacitive 
coupling and thus results in an increase in the gate current. This is schematically shown in Figure 4.10 
and is confirmed by the measured data in Figure 4.12.  
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Figure 4.11: Decrease in drain current due to loss of electron after MIG/anti-MIG binding. 
 
 
 
Figure 4.12: Measurement of drain current for clean device, after anti-MIG immobilization and after MIG exposure. 
Current reduces by 1.9mA due to recombination of anti-MIG and MIG. 
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The recombinant human MIG exposed to the device sensing gate binds specifically with the previously 
immobilized anti-MIG IgG molecules. The corresponding changes in the net charge of the MIG/anti-MIG 
complex modulate the electrical properties of the HEMT FET sensing channel. These results in loss of the 
electron gained in the previous anti-MIG immobilization and cause a decrease in the drain current. As 
already indicated above, this is shown in Figure 4.11 and is confirmed by the measured data in Figure 
4.12. The experimental results confirm the sensitive detection of the MIG by the anti-MIG monoclonal 
antibody. 
 
Experiments were carried out using various concentrations of MIG, ranging from 5 ng/mL to 500 ng/mL. 
It was observed that at low concentrations range the increasing MIG concentration decreased the 
differential current due to anti-MIG/MIG recombination. As the anti-MIG concentration was held 
constant, increasing MIG concentration results in a gradual increase in the drain current after 
immobilization due to the presence of the positive charge on the MIG. As a result, the differential current 
before and after the immobilization of MIG is gradually decreased as shown in Figure 4.13. Figure 4.14 
represents the reproducibility of the result with three sets of test data at 5ng/mL concentration of MIG that 
fall within the standard error bars. 
 
As MIG concentration was further increased, the positively charged MIG dominates the net charge at the 
gate. Due to the dominating positive gate charges, electrons are attracted to the channel resulting in the 
increase in the drain current. Eventually the current after immobilization of the MIG becomes greater than 
the current prior to the immobilization. As a result, the differential current increases in the negative 
direction, which is confirmed by Figure 4.13. 
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Figure 4.13: Decrease in differential drain current with increase in MIG concentration. Vds is kept fixed at 2 V. 
 
 
 
Figure 4.13: Standard error bars demonstrating the reproducibility of the results. The concentration of MIG was 
maintained at 5ng/mL. 
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4.5 Conclusion 
Using the same device, a novel way for detecting two different kinds of biomolecules is demonstrated, 
which promises the potential of detecting multiple biomolecule in a single chip. As such, the sensor can 
be further developed for point of care applications for the detection of biomarkers of complex diseases 
such as different types of cancers, where detecting only one or two biomarkers may give ambiguous 
results. The device can be integrated with microfluidic channels to control the flow of target analyte to the 
area of interest and with other signal processing and transmission circuitry to have a lab on a chip. 
 
In addition, the results reported here is the first for the detection of native recombinant human MIG in 
physiologically relevant buffer environment (150 mM PBS). This shows the potential of the devices for 
use in the detection of biomarkers in an ionic strength environment corresponding to that present in 
human blood. This possibility will eliminate the need for the extra steps required to extract the target 
biomarkers and prepare diluted solution before detection. 
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Chapter 5 
Charge Control Model of HEMT 
 
5.1 Introduction 
This chapter focuses on the development of a physics based analytical model of AlGaN/GaN HEMT. The 
development of 2D electron gas (2DEG) in HEMT structure is investigated in details. Both spontaneous 
and piezoelectric effects of polarization in channel charge are considered. A quasi-triangular quantum 
well is considered in the heterojunction. The sheet carrier density of the 2DEG is expressed via a non-
linear equation. The non-linear equation of charge is simplified based on realistic approximation and the 
current voltage relationship of the HEMT device is developed. The effect of drift velocity and electric 
field is also included via an empirical model. 
 
5.2 Development of 2D Electron Gas in AlGaN/GaN HEMT 
The crystalline structure of GaN can be both Zinc blende and Wurtzite (Figure 5.1). It is normally grown 
on the Ga-face, along the c-axis.  
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Figure 5.1: Crystalline structure of GaN. 
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Because of the noncentrosymmetry in its crystalline structure, GaN exhibits a substantial spontaneous 
electrical polarization (Psp) perpendicular to the hexagonal plane, and in the direction down into the Ga-
face surface, as shown in Figure 5.2. When AlGaN is grown on GaN, larger electrical polarization results 
in the same direction. Moreover, since AlGaN has a smaller lattice constant than GaN, the two-
dimensional tension at the interface induces a piezoelectric polarization component (Ppe) which adds to 
the spontaneous polarization [53].  
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Figure 5.2: Polarization properties of AlGaN and GaN materials. 
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The total electrical polarization (Pt) between the pseudomorphic AlGaN top barrier layer and the GaN 
channel layer is obtained by the algebraic sum of individual components as given by equation 5.1.  
𝑃𝑡 = 𝑃𝑠𝑝(𝐴𝑙𝐺𝑎𝑁) − 𝑃𝑠𝑝(𝐺𝑎𝑁) + 𝑃𝑝𝑒(𝐴𝑙𝐺𝑎𝑁)    (5.1) 
A positive sheet charge density (Q) appears due to the net polarization effect, which causes an 
accumulation of electrons at the interface and thus forms the 2-DEG (Figure 5.3). Therefore, even without 
any intentional doping in the AlGaN layer, a high charge density channel is formed at the heterointerface. 
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Figure 5.3: Formation of 2DEG at AlGaN/GaN hetero-interface due to spontaneous and piezoelectric polarization. 
 
 
 
Especially in wurtzite AlGaN/GaN based transistor structures; the piezoelectric polarization of the 
strained top layer is more than five times larger as compared to that of AlGaAs/GaAs structures, leading 
to a significant increase of the sheet carrier concentration at the interface [74]. 
 
The amount of charge density due to spontaneous charge density in case of AlGaN is 0.055 C/m2 [75]. 
The Amount of charge density because of piezoelectric polarization is given by  
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𝑄𝑝𝑒 = 2
𝑎𝐺𝑎𝑁−𝑎𝐴𝑙𝐺𝑎𝑁
𝑎𝐴𝑙𝐺𝑎𝑁
(𝑒31 − 𝑒33
𝐶13
𝐶33
)     (5.2) 
where, a is the lattice constant of the material, e is the piezoelectric co-efficient and C is the relevant 
elastic constant. 
 
5.3 Non-linear Charge Control Model 
The first model to predict the charge concentration at the heterojunction of a HEMT device was proposed 
by D. Delagebeaudeuf and N. T. Linh [76]. Based on AlGaAs/GaAs HEMT, they proposed that the 
charge concentration at the 2DEG is given by 
𝑄𝑠 = 𝑞𝑛𝑠 =  
𝜖2
𝑑
 (𝑉𝑔 −
𝐸𝐹
𝑞
− 𝑉𝑜𝑓𝑓)              
where, Qs is the channel charge, ns is the sheet carrier density, ϵ2 is the permittivity of the higher bandgap 
material, d is the effective distance between the Schottky gate and 2DEG, EF is the Fermi energy at the 
interface, Vg is the applied gate voltage, and Voff is the voltage that annihilates the 2DEG and is given by 
𝑉𝑜𝑓𝑓 = 𝜑𝐵 −
∆𝐸𝑐
𝑞
−
𝑞𝑁2
2𝜖2
(𝑑 − 𝑒)2 −
𝑑
𝜖2
𝑄𝑖     (5.3) 
where, φB is the Schottky barrier height, ΔEC is the conduction band offset at the hetero-interface, e is the 
thickness of the spacer layer, Qi is the interface state charge.  
Now, EF is dependent on Vg and results in a nonlinear equation for ns, and in case of a triangular potential 
well, the relationship between EF and ns is given by [77] 
𝐸𝐹 = 𝐸𝐹0 + 𝛾𝑛𝑠
2
3          
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where, EF0 is equilibrium Fermi level and γ is a constant linking the 2DEG carrier density with the 
longitudinal quantized energy. This approximation is valid as long as the device is not operated in the 
deep subthreshold region. 
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Figure 5.4: Energy band diagram of AlGaN/GaN HEMT. 
 
For AlGaN/GaN HEMT devices, equation 5.3 can be modified depending on the Energy band diagram as 
shown in Figure 5.4 as follows [78]: 
𝑛𝑠(𝑥) =
𝑄𝑠
𝑞
=  
𝑞∈2
𝑞2𝑑+∈2𝑎
 (𝑉𝑔 − 𝑉(𝑥) − 𝑉𝑡ℎ)        (5.4) 
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where,  a is the quantum well shape factor, V(x) is the channel potential at x, Vth is the threshold voltage, 
and d = dd + dr +Δd, where dd is the thickness of AlGaN layer, dr is the roughness of gate metal and Δd is 
the offset of the 2-DEG from the hetero-interface. 
The threshold voltage Vth is given by  
𝑉𝑡ℎ = 𝑉𝑜𝑓𝑓 + 𝐸𝐹       
For AlGaN/GaN HEMT, Voff is defined by 
𝑉𝑜𝑓𝑓 = 𝜑𝐵 −
∆𝐸𝑐
𝑞
−
𝑞𝑁2
2𝜖2
𝑑2       
Using equation 5.4, the equation for sheet carrier density can be rewritten as  
𝑛𝑠(𝑥) =  
𝑞∈2
𝑞2𝑑+∈2𝑎
 (𝑉𝑔 − 𝑉(𝑥) − 𝜑𝐵 +
∆𝐸𝑐
𝑞
+
𝑞𝑁2
2𝜖2
𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠
2
3)     (5.5) 
 
5.4 Current Voltage Characteristics 
The drain current is given by [79], 
𝐼𝑑 = 𝑞𝑛𝑠𝑍𝑣(𝑥)        (5.6) 
where, Z is the gate width and v(x) is the electron drift velocity. The relationship between the drift 
velocity and the electric field used by in this work is expressed as [29], 
𝑣(𝑥) =
𝑣𝑠𝐸(𝑥)
√𝐸2(𝑥)+(
𝑣𝑠
𝜇0
)
2
        (5.7) 
where, vs is the saturation drift velocity and μ0 is the low-field mobility. 
Using equations 5.5 to 5.7, the drain current equation can be written as 
𝐼𝑑 =
𝑞2∈2
𝑞2𝑑+∈2𝑎
 (𝑉𝑔 − 𝑉(𝑥) − 𝜑𝐵 +
∆𝐸𝑐
𝑞
+
𝑞𝑁2
2𝜖2
𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠
2
3) 𝑍
𝑣𝑠𝐸(𝑥)
√𝐸2(𝑥)+(
𝑣𝑠
𝜇0
)
2
  (5.8) 
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5.4.1 Drain Current Before Saturation 
From the boundary conditions, it is obvious that V(x) = 0 at x = 0, and V(x) = Vds at x = L, where L is the 
length of the HEMT. 
From equation 5.8, 
𝐼𝑑,0 =
𝑞2 ∈2
𝑞2𝑑 +∈2 𝑎
 (𝑉𝑔 − 𝜑𝐵 +
∆𝐸𝑐
𝑞
+
𝑞𝑁2
2𝜖2
𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠
2
3) 𝑍
𝑣𝑠𝐸(𝑥)
√𝐸2(𝑥) + (
𝑣𝑠
𝜇0
)
2
 
𝐼𝑑,𝐿 =
𝑞2 ∈2
𝑞2𝑑 +∈2 𝑎
 (𝑉𝑔 − 𝑉𝑑𝑠 − 𝜑𝐵 +
∆𝐸𝑐
𝑞
+
𝑞𝑁2
2𝜖2
𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠
2
3) 𝑍
𝑣𝑠𝐸(𝑥)
√𝐸2(𝑥) + (
𝑣𝑠
𝜇0
)
2
 
From equation 5.8, 
𝐼𝑑 = 𝐾1  (𝑉𝑔 − 𝑉(𝑥) − 𝐾2 − 𝛾𝑛𝑠
2
3) 𝑍
𝑣𝑠𝐸(𝑥)
√𝐸2(𝑥)+𝛽
  
 
where,   𝐾1 =
𝑞2∈2
𝑞2𝑑+∈2𝑎
 and 𝐾2 = 𝜑𝐵 −
∆𝐸𝑐
𝑞
−
𝑞𝑁2
2𝜖2
𝑑2 + 𝐸𝐹0, and  𝛽
2 = (
𝑣𝑠
𝜇0
)
2
 
So, 
𝛽2
𝐸2(𝑥)
=
𝐾1 (𝑉𝑔−𝑉(𝑥)−𝐾2−𝛾𝑛𝑠
2
3)𝑍𝑣𝑠
𝐼𝑑
− 1     
Since 𝐸(𝑥) = − 
𝑑𝑉(𝑥)
𝑥
, 
−𝛽𝑑𝑥 = {
𝐾1 (𝑉𝑔−𝑉(𝑥)−𝐾2−𝛾𝑛𝑠
2
3)𝑍𝑣𝑠
𝐼𝑑
− 1}
1/2
𝑑𝑉(𝑥)   
Or, 
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𝑑𝑉(𝑥) = −
𝛽
(
𝐺(𝑥)
𝐼𝑑
−1)
1/2 𝑑𝑥     (5.9) 
where, 𝐺(𝑥) = 𝐾1  (𝑉𝑔 − 𝑉(𝑥) − 𝐾2 − 𝛾𝑛𝑠
2
3(𝑥)) 𝑍𝑣𝑠. 
By integrating equation 5.9 from x = 0 to x = L, the drain current equation before saturation is obtained 
using the boundary conditions. 
 
5.4.2 Drain Current After Saturation 
Saturation is achieved when channel conductance gm becomes zero. 
𝑔𝑚 =
𝜕𝐼𝑑
𝜕𝑉𝑑𝑠
= 0  
Because of the current continuity at the onset of saturation, 
𝐼𝑑,𝑠𝑎𝑡 =
𝑞2∈2
𝑞2𝑑+∈2𝑎
 (𝑉𝑔 − 𝑉𝑑𝑠 − 𝜑𝐵 +
∆𝐸𝑐
𝑞
+
𝑞𝑁2
2𝜖2
𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠
2
3) 𝑍
𝑣𝑠𝐸𝑠𝑎𝑡
√𝐸𝑠𝑎𝑡
2 +(
𝑣𝑠
𝜇0
)
2
 (5.10) 
where, 𝐸𝑠𝑎𝑡 = −
𝑉𝑠𝑎𝑡
𝐿𝑠𝑎𝑡
. 
To find out Vsat and Lsat, two dimensional Poisson’s equation in the pinch-off region can be solved which 
results in [77] 
𝑉𝑑 − 𝑉𝑠𝑎𝑡 =
2𝐸𝑠𝑑𝑠
𝜋
𝑠𝑖𝑛ℎ [
𝐿−𝐿𝑠𝑎𝑡
2𝑑𝑠
]  
where,  
𝑑𝑠 = 𝑑 {1 + 𝛾 (
𝜖2
𝑞𝑑
)
2/3
(𝑉𝑔 − 𝑉𝑡ℎ − 𝑉𝑠𝑎𝑡)
−1/3
}  
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5.5 Comparison of Measurement and Simulation Results 
The current voltage characteristics of test devices are obtained by Keithley 4200 semiconductor parameter 
analyzer and Signatone DC probe station. The transfer characteristics is obtained by keeping the drain to 
source voltage constant. Figure 5.5 shows the comparison of measured and simulated Id – Vgs curve at Vds 
= 5 V. The threshold voltage of the HEMT device is observed to be -4.56 V. 
 
 
Figure 5.5: Measured and simulated transfer characteristics (Id-Vgs) of the AlGaN/GaN HEMT device. Vds is kept 
fixed at 5V. 
 
The output characteristics is obtained at varying gate voltage by keeping Vgs constant a particular bias and 
varying Vds from 0V to 5V. The drain current before saturation and after saturation are calculated using 
equations 5.9 and 5.10. It is observed that the model overestimates the drain current at higher voltages, 
since a constant resistant throughout the channel is considered. 
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The output characteristics curves are measured for gate voltage of -2V to +2V by step increment. The 
measured and simulated Id – Vds curve is shown in Figure 5.6. For low values of voltage, the simulated 
curves match the measured output characteristics. But for higher voltages, some discrepancy is observed 
since the as the secondary effects of the channel saturation such as channel length modulation become 
prominent, which are ignored in the proposed model for the sake of simplicity.  
 
 
Figure 5.6: Measured and simulated output characteristics (Id-Vds) of HEMT device. Vgs is varied from -2V to +2V. 
Vds is varied from 0V to 5V 
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Chapter 6 
Floating Gate Model for BioFET 
6.1 Introduction 
This chapter focuses on the development of a floating gate model suitable for predicting the behavior of 
biosensor platform. The nonlinear charge control model for evaluation of the drain current as discussed in 
the previous chapter depends on the applied gate voltage. But in case of biosensor, an applied gate voltage 
will nullify any effect of the charged biomolecules immobilized on the gate surface. As such, a model is 
required that predicts the modulation of the channel charge in response of the immobilized gate charge 
instead of applied gate voltage. 
 
This chapter explains the mechanism of how the charged biomolecules modulate the channel charge 
underneath the gate and modifies the analytical model developed in the previous chapter into a floating 
gate model. 
 
6.2 Charge Coupling Through Gate Capacitance 
Target biomolecules are immobilized on the gate by functionalization of the HEMT sensor. Once 
immobilized, the charged biomolecules are linked to the channel charge via capacitive coupling method. 
A positive charge on the gate will induce more electrons in the 2DEG below and result in the increase in 
the drain current. A negative charge on the gate on the other hand will repel electrons from the 2DEG. 
The loss of electron in the channel will be reflected via a reduction in the drain current. Since no external 
voltage is applied, the configuration is considered to be a floating gate condition. The capacitive coupling 
of the charge molecules will change the electric field distribution and as such will be reflected as floating 
gate voltage. 
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Figure 6.1: Schematic of floating gate AlGaN/GaN HEMT with gold contacts at gate, drain and source region. 
Target biomolecules are adsorbed onto the gold contacts of the gate and become capacitively coupled to the channel 
underneath. 
 
 
The relationship between the floating gate charge Qfg, the reflected voltage at the floating gate Vfg, and the 
gate-to-channel capacitance Cgc is simply given by 
𝑄𝑓𝑔 = 𝐶𝑔𝑐𝑉𝑓𝑔         (6.1) 
This gate charge will affect the electrostatic distribution in the channel and modify the sheet carrier 
density according to the following equations: 
 
𝑛𝑠 =
𝑄𝑠
𝑞
=  
∈2
𝑑
 (𝜑𝑏 +
𝐸𝐹
𝑞
−
∆𝐸𝑐
𝑞
+ 𝑉𝑐(𝑥))      (6.2) 
 
𝑛𝑠 + ∆𝑛 =  
∈2
𝑑
 (𝜑𝑏 +
𝐸𝐹
𝑞
−
∆𝐸𝑐
𝑞
+ 𝑉𝑐(𝑥) −
∆𝑑+𝑑𝑑
𝑑
𝑉𝑓𝑔)   (6.3) 
 
where, Qs is the channel charge, Δn is the modified sheet carrier density due to the floating gate voltage, 
ϵ2 is the permittivity of AlGaN, φb is the Schottky barrier height, EF is the Fermi energy at the interface 
relative to the GaN conduction-band-edge, ΔEC is the conduction band offset at the AlGaN/GaN interface, 
VC(x) is the channel potential at x, and d = dd + dr +Δd, where dd is the thickness of AlGaN layer, dr is the 
roughness of gate metal and Δd is the offset of the 2-DEG from the heterointerface.  
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6.3 Current Voltage Characteristics 
The sheet carrier density from equations 6.2 and 6.3 can be used to calculate the drain current before and 
after the immobilization of the biomolecules via equations 6.4 and 6.5 as shown below, 
 
  𝐼𝐷 = 𝑞𝑛𝑠𝑍𝜈(𝑥)       (6.4) 
                          
𝐼𝐷 + ∆𝐼𝐷 = 𝑞(𝑛𝑠 + ∆𝑛)𝑍𝜈(𝑥)       (6.5) 
                    
where, the drift velocity is replaced by the velocity-electric field empirical relationship of the previous 
chapter and we get 
 
  𝐼𝐷 = 𝑞
∈2
𝑑
 (𝜑𝑏 +
𝐸𝐹
𝑞
−
∆𝐸𝑐
𝑞
+ 𝑉𝑐(𝑥)) 𝑍
𝜈𝑠𝐸(𝑥)
√𝐸2(𝑥)+(
𝜈𝑠
𝜇0
)
2
   (6.6) 
 
𝐼𝐷 + ∆𝐼𝐷 = 𝑞
∈2
𝑑
 (𝜑𝑏 +
𝐸𝐹
𝑞
−
∆𝐸𝑐
𝑞
+ 𝑉𝑐(𝑥) −
∆𝑑+𝑑𝑑
𝑑
𝑉𝑓𝑔) 𝑍
𝜈𝑠𝐸(𝑥)
√𝐸2(𝑥)+(
𝜈𝑠
𝜇0
)
2
  (6.7) 
 
where, vs is the saturation velocity of electrons in GaN, 0 is the low-field mobility of electron in the 2-
DEG. 
The mechanism of change in drain current before and after the immobilization of biomolecules is shown 
in Figure 6.2. 
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Figure 6.2:  Changes in the drain current due to biomolecule immobilization: (a) Current before immobilization of 
biomolecules, (b) Current after the immobilization of biomolecules. 
 
From equations 6.6 and 6.7, the change in the drain current due to the immobilized biomolecules can be 
given by 
 
∆𝐼𝐷 = 𝑞
∈2
𝑑
 (−
∆𝑑+𝑑𝑑
𝑑
𝑉𝑓𝑔) 𝑍
𝜈𝑠𝐸(𝑥)
√𝐸2(𝑥)+(
𝜈𝑠
𝜇0
)
2
    (6.8) 
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6.4 Effect of Threshold Voltage Shift 
The threshold voltage changes due to the dipoles of the target biomolecules, which can be written as [80, 
81] 
∆𝑉𝑡ℎ =
𝜇𝑑𝑖𝑝𝑁𝑏
𝜖
       (6.9) 
where, µdip and ϵ are the dipole moment and the dielectric permittivity of the biomolecule, respectively, Nb 
is the surface density of the charged molecules vertically oriented on the gate.  
 
Under floating gate condition, the sheet carrier density, ns(x) is redefined from equation 5.5 by, 
𝑛𝑠(𝑥) + ∆𝑛𝑠 =
∈2
𝑞(𝑑𝑑+∆𝑑)
(−𝑉(𝑥) − 𝑉𝑡ℎ − ∆𝑉𝑡ℎ)     (6.10) 
where, V(x) is the voltage along the x-direction in the 2-DEG channel due to applied drain bias [9, 10]. 
𝑉𝑡ℎ = 𝜑𝐵 −
∆𝐸𝑐
𝑞
−
𝑁𝑑𝑑
𝜖2
+
𝐸𝐹
𝑞
    (6.11) 
 
where, N is the sheet charge density due to spontaneous and piezoelectric polarizations. 
From equations 6.9 to 6.11, the change in sheet carrier density due to shift in threshold voltage can be 
expressed by  
 
∆𝑛𝑠 =
∈2
𝑞(𝑑𝑑+∆𝑑)
(−
𝜇𝑑𝑖𝑝𝑁𝑏
𝜖
)      (6.12) 
As such, the change in the drain current can be given by 
 
∆𝐼𝐷 =
∈2
(𝑑𝑑+∆𝑑)
(−
𝜇𝑑𝑖𝑝𝑁𝑏
𝜖
) 𝑍
𝜈𝑠𝐸(𝑥)
√𝐸2(𝑥)+(
𝜈𝑠
𝜇0
)
2
     (6.13) 
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6.5 Comparison of Measurement and Simulation Results 
The changes in the drain current before and after the immobilization of the target biomolecules are 
measured using Keithly 4200 semiconductor parameter analyzer and Signatone Checkmate probe station. 
The measured test data is compared with the simulation results based on the proposed floating gate 
model, as shown in Figure 6.3. For low values of drain voltage (upto 2V), the measured data closely 
follows the simulation data. 
It is also observed from test data that as biomolecule concentration at the gate increases, the drain current 
reaches saturation at a lower reflected gate voltage. It is because increased biomolecule concentration at 
the gate increases the net charge available at the gate. As a result, the required voltage to reach peak 
current is decreased. This phenomenon is exhibited in Figure 6.4. 
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Figure 6.3: Simulated and measured changes in the drain current due to immobilization of target biomolecule. 
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Figure 6.4: Variation in Vds at which peak differential current occurs with the increase in biomolecule 
concentration. The x axis is shown in logarithmic scale for better comprehension. 
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Chapter 7 
 
Discussions and Conclusions 
6.1 Conclusions 
Different biosensor platforms have been investigated in detail in this work. After careful comparison of 
these biosensor platforms, AlGaN/GaN HEMT based biosensor platform is chosen for the detection of 
multiple biomolecules. An analytical model considering the effect of polarization which forms a 2DEG in 
a triangular quantum well is proposed. Based on the physics based analytical model, a floating gate model 
has been derived to predict the behavior of the AlGaN/GaN HEMT based biosensor platform.  
 
The original contributions, as pointed out by this work are: 
 
 Configuring an AlGaN/GaN HEMT as a bioFET for the first time. 
 Detection of multiple target biomolecules using the same platform. 
 Measurement of target biomolecule (MIG) in physiologically relevant environment for the 
first time. 
 Improving the existing model of HEMT by including the effect of polarization which creates 
the channel in AlGaN/GaN HEMT. 
 Predicting the behavior of the proposed bioFET by modifying the proposed model in a 
floating gate configuration.  
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6.2 Future Works 
Compared to Si technology, AlGaN/GaN devices are still at the preliminary stages of their development 
and fabrication. As such, gate leakage, traps and surface defects are some still hinder the 
commercialization of high performance wide bandgap GaN devices. But because of their immense 
prospect, GaN might be the device of the future. As such, a physics-based analytical model to predict the 
device behavior is of utmost importance. Including the effects of following phenomena would help 
understand the device behavior more accurately: 
 Parasitic parallel conduction for higher gate voltage 
 Variation of drain and source resistances with gate voltage and temperature 
 Leakage currents 
 Trapping effects 
In this work, the DC current-voltage characteristics of AlGaN/GaN HEMT have been validated by the 
measured data. The proposed model is also used to predict the behavior of a biosensor realized in 
AlGaN/GaN HEMT platform for two different kinds of biomolecules for in vitro sensing. The biosensor 
platform can be improved by investing the following conditions:  
 Including the effect of interferers that might be present in relevant physiological 
condition for in vivo sensing. 
 Validating the model using other charged biomolecules. 
 Developing a lab-on-a-chip platform by transferring the output of the HEMT to the signal 
processing unit. 
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